COMPANY Testing Responsibility. 7.3.1 Batch release documents will be evaluated by COMPANY upon receipt for conformance to Specifications and applicable cGMP requirements. COMPANY will not be performing additional testing to the AMGEN released batches.
Appears in 6 contracts
Sources: Exclusive License Agreement (Atara Biotherapeutics, Inc.), Exclusive License Agreement (Atara Biotherapeutics, Inc.), Exclusive License Agreement (Atara Biotherapeutics, Inc.)